Adrenomedullin vs Catestatin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Adrenomedullin (ADM) is a 52-amino acid vasoactive peptide first isolated from human pheochromocytoma tissue in 1993. It is now recognized as a pleiotropic hormone produced widely throughout the body, with highest expression in the adrenal medulla, heart, lung, kidney, and vascul...
Calculate Adrenomedullin dose →Catestatin is a 21-amino acid peptide derived from the chromogranin A (CgA) protein, specifically cleaved from the region spanning residues 352-372. It was identified as an endogenous inhibitor of catecholamine secretion, acting as a non-competitive antagonist at nicotinic acetyl...
Calculate Catestatin dose →| Parameter | Adrenomedullin | Catestatin |
|---|---|---|
| Category | Cardiovascular Peptide | Cardiovascular Peptide |
| Research | Clinical | Preclinical / Early Human |
| Half-Life | 22 min (plasma) | ~15-30 minutes (IV) |
| Typical Dose | 2-10 ng/kg/min (IV infusion) | 0.3-3 nmol/kg (animal studies) |
| Frequency | Acute infusion or short course | Acute dosing in research |
| Route | Intravenous, Subcutaneous | IV (research); intranasal under study |
| FDA Status | Not approved | Research compound |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.